Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients

被引:46
作者
Cova, Emanuela
Cereda, Cristina
Galli, Alberto
Curti, Daniela
Finotti, Chiara
Di Poto, Cristina
Corato, Manuel
Mazzini, Giuliano
Ceroni, Mauro
机构
[1] Fdn C Mondino, IRCCS, Inst Neurol, Lab Expt Neurobiol, I-27100 Pavia, Italy
[2] Policlin Monza, Dept Neurol, I-20052 Monza, Italy
[3] Univ Pavia, Dept Cellular & Mol Physiol & Pharmacol Sci, I-27100 Pavia, Italy
[4] Univ Pavia, Dept Anim Biol, IGM CNR, I-27100 Pavia, Italy
[5] Univ Pavia, Dept Neurosci, I-27100 Pavia, Italy
关键词
amyotrophic lateral sclerosis; lymphocytes; oxidative stress; Bcl-2; SOD1; catalase;
D O I
10.1016/j.neulet.2006.01.057
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Markers of oxidative stress have been found in spinal cord, cortex, cerebrospinal fluid, and plasma of SALS patients. Mitochondrial and calcium metabolism dysfunction were also found in peripheral lymphocytes from SALS patients. In this study, we demonstrate that lymphocytes from SALS patients are more prone to undergo alteration of cell membrane integrity both in basal conditions and following oxidative stress induced by H2O2 treatment. The expression of the antioxidant proteins, Bcl-2, SOD1 and catalase in basal conditions, was significantly lower in lymphocytes from SALS patients than in lymphocytes from age and sex matched controls. Exposure to H2O2 induced a time-dependent decrease of Bcl-2 and SOD1 in control lymphocytes. Conversely, the levels of these proteins remained unchanged in SALS lymphocytes even after 18 h stress. Catalase expression was not significantly modified by oxidative stress. Our results demonstrate that two factors involved in the genesis and/or progression of the familial form of the disease with SOD I mutation are altered also in the sporadic form of ALS and suggest that the oxidative stress protection pathway is deregulated in lymphocytes from ALS patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 31 条
[1]  
Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO
[2]  
2-8
[3]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[4]   Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation [J].
Ceroni, M ;
Malaspina, A ;
Poloni, TE ;
Alimonti, D ;
Rognoni, F ;
Habgood, J ;
Imbesi, F ;
Antonelli, P ;
Alfonsi, E ;
Curti, D ;
deBelleroche, J .
NEUROLOGY, 1999, 53 (05) :1064-1071
[5]   Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases [J].
Choi, J ;
Rees, HD ;
Weintraub, ST ;
Levey, AI ;
Chin, LS ;
Li, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :11648-11655
[6]   Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes [J].
Curti, D ;
Malaspina, A ;
Facchetti, G ;
Camana, C ;
Mazzini, L ;
Tosca, P ;
Zerbi, F ;
Ceroni, M .
NEUROLOGY, 1996, 47 (04) :1060-1064
[7]  
de la Monte S. M., 2000, Journal of Alzheimer's Disease, V2, P261
[8]  
Ekegren T, 1999, ACTA NEUROL SCAND, V100, P317
[9]  
Embacher N, 2001, ACTA NEUROPATHOL, V102, P426
[10]  
Ferrante RJ, 1997, J NEUROCHEM, V69, P2064